Grant: Discovery Grants Program - Individual
University of Manitoba
$25,000.00
Novel Acoustic Technologies for Obstructive Sleep Disorders Diagnosis and Treatment Monitoring
FY 2014-15
Summary
The proposed research falls at the interface between engineering and medicine. Its focus is to develop new engineering approaches to signal processing and instrumentation in order to address the challenging medical problem of obstructive sleep apnea (OSA). Specifically, we will develop non-invasive and effective technologies that can readily be applied in a clinical setting in order to better understand the mechanism and diagnosis of the disorder. OSA is a common and serious respiratory disorder with major comorbidities such as memory loss, increased risk of accidents, and cardiovascular disease. It is characterized by recurrent episodes of partial or complete obstruction of the upper airway and is usually associated with drop of blood oxygen saturation and frequency arousals (waking up). OSA is highly prevalent in the Canadian adult population and also in children and is also a major but hidden cause of cardiovascular diseases. Importantly, OSA is treatable but is massively underdiagnosed. To find and treat those who are impacted by OSA, a simple technology for risk assessment is urgently needed. The long term objective of this proposal is to fill that gap. We propose a novel, non-invasive and cost-effective for use in clinical settings. Based upon acoustic technology, we will monitor significant airway narrowing, diagnose OSA and its severity, and identify the site of obstruction and the response to treatment. These goals will be achieved through non-invasive tracheal respiratory sound analysis during the experimental procedures in collaboration with the medical colleagues. Outcomes of this research are: to advance our understanding of the mechanism of upper airway obstruction and its associated disorders; to develop non-invasive, cost effective and quick diagnostic tools; and therefore improve the quality of life of a large population affected by OSA.
Program
Discovery Grants Program - Individual
Recipient
Location
Manitoba, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
222958-2012
Name nom
KazemMoussavi, Zahra
Department département
Electrical and Computer Engineering
Organization id
19
Institution établissement
University of Manitoba
Province en
Manitoba
Province fr
Manitoba
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2014
Competition year année de concours
2012
Award amount
25000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1510
Committee name en
Electrical and Computer Engineering
Committee name fr
Génie électrique et informatique
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Partie
3
Nb partie
5
Application title
Novel Acoustic Technologies for Obstructive Sleep Disorders Diagnosis and Treatment Monitoring
Keyword
NSERC
Application summary
The proposed research falls at the interface between engineering and medicine. Its focus is to develop new engineering approaches to signal processing and instrumentation in order to address the challenging medical problem of obstructive sleep apnea (OSA). Specifically, we will develop non-invasive and effective technologies that can readily be applied in a clinical setting in order to better understand the mechanism and diagnosis of the disorder. OSA is a common and serious respiratory disorder with major comorbidities such as memory loss, increased risk of accidents, and cardiovascular disease. It is characterized by recurrent episodes of partial or complete obstruction of the upper airway and is usually associated with drop of blood oxygen saturation and frequency arousals (waking up). OSA is highly prevalent in the Canadian adult population and also in children and is also a major but hidden cause of cardiovascular diseases. Importantly, OSA is treatable but is massively underdiagnosed. To find and treat those who are impacted by OSA, a simple technology for risk assessment is urgently needed. The long term objective of this proposal is to fill that gap. We propose a novel, non-invasive and cost-effective for use in clinical settings. Based upon acoustic technology, we will monitor significant airway narrowing, diagnose OSA and its severity, and identify the site of obstruction and the response to treatment. These goals will be achieved through non-invasive tracheal respiratory sound analysis during the experimental procedures in collaboration with the medical colleagues. Outcomes of this research are: to advance our understanding of the mechanism of upper airway obstruction and its associated disorders; to develop non-invasive, cost effective and quick diagnostic tools; and therefore improve the quality of life of a large population affected by OSA.